| Nome |
# |
|
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis, file e291c0d4-9e9e-cddb-e053-3a05fe0aa144
|
973
|
|
Moving exercise research in multiple sclerosis forward (the MoXFo initiative): developing consensus statements for research, file e291c0d7-b63a-cddb-e053-3a05fe0aa144
|
568
|
|
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study, file e291c0d7-6019-cddb-e053-3a05fe0aa144
|
376
|
|
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence, file 1b2c9ecf-efa7-4a69-8134-66240a9328d5
|
242
|
|
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression, file e291c0d6-0a50-cddb-e053-3a05fe0aa144
|
203
|
|
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis, file e291c0d6-0dfe-cddb-e053-3a05fe0aa144
|
197
|
|
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis, file e291c0d6-088e-cddb-e053-3a05fe0aa144
|
191
|
|
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis, file e291c0d7-bec8-cddb-e053-3a05fe0aa144
|
160
|
|
The Link Among Neurological Diseases: Extracellular Vesicles as a Possible Brain Injury Footprint, file e291c0d8-435b-cddb-e053-3a05fe0aa144
|
149
|
|
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine, file e291c0d6-d1c0-cddb-e053-3a05fe0aa144
|
142
|
|
PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis, file e291c0d6-d91a-cddb-e053-3a05fe0aa144
|
135
|
|
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum, file e291c0d8-6b3f-cddb-e053-3a05fe0aa144
|
107
|
|
A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4, file e291c0d8-3947-cddb-e053-3a05fe0aa144
|
91
|
|
Synaptic plasticity shapes brain connectivity: Implications for network topology, file e291c0d8-183e-cddb-e053-3a05fe0aa144
|
88
|
|
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients, file e291c0d8-4b4d-cddb-e053-3a05fe0aa144
|
85
|
|
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals, file e291c0d8-062f-cddb-e053-3a05fe0aa144
|
84
|
|
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study), file e291c0d8-436d-cddb-e053-3a05fe0aa144
|
83
|
|
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma, file e291c0d8-4904-cddb-e053-3a05fe0aa144
|
81
|
|
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity, file e291c0d8-5122-cddb-e053-3a05fe0aa144
|
81
|
|
CCF-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders, file e291c0d8-4362-cddb-e053-3a05fe0aa144
|
76
|
|
Fingolimod Immune Effects Beyond Its Sequestration Ability, file e291c0d8-77f2-cddb-e053-3a05fe0aa144
|
76
|
|
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis, file e291c0d8-6972-cddb-e053-3a05fe0aa144
|
74
|
|
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis, file e291c0d5-2a13-cddb-e053-3a05fe0aa144
|
69
|
|
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany, file e291c0d8-16e9-cddb-e053-3a05fe0aa144
|
68
|
|
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis, file e291c0d8-3b2c-cddb-e053-3a05fe0aa144
|
67
|
|
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients, file e291c0d8-4446-cddb-e053-3a05fe0aa144
|
67
|
|
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis, file e291c0d8-abed-cddb-e053-3a05fe0aa144
|
60
|
|
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis, file 68fefcf9-9c56-4fd7-a58a-564936c96c88
|
54
|
|
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2, file e291c0d8-5a7e-cddb-e053-3a05fe0aa144
|
50
|
|
Osteopontin Is Associated with Multiple Sclerosis Relapses, file 2683a1bd-f316-480a-b7d5-bfed56e5ea3a
|
37
|
|
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort, file 363fca47-7050-4f78-be6e-b335cf819076
|
36
|
|
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model, file 0c9a2cc7-3b70-41ab-9f6c-e918c42058a3
|
25
|
|
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases, file 6f9c6d65-0227-49d9-b010-ec6e1ce0bf5e
|
24
|
|
Ofatumumab and Early Immunological Cells Subset Characterization in Naïve Relapsing Multiple Sclerosis Patients: A Real-World Study, file 0fbeb613-7ff8-4c09-9a4c-ebd9c646d01a
|
23
|
|
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis, file 22febe4c-2761-4156-b0cd-fdf429bdda14
|
19
|
|
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study), file 55d7ac12-510c-4d01-b5ca-599689035ec5
|
16
|
|
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients, file ee493b81-48ab-4222-9698-e2e76205e9f8
|
16
|
|
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis, file cec7e781-9506-4031-90b0-1c7649948541
|
12
|
|
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab, file 00a5d1e2-061b-4754-8fc3-77984c946481
|
11
|
|
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray), file 6f26a669-62c5-4146-b03e-cc69eeb917d3
|
10
|
|
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis, file e291c0d7-a79f-cddb-e053-3a05fe0aa144
|
9
|
|
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis, file e291c0d7-a79d-cddb-e053-3a05fe0aa144
|
8
|
|
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML, file e291c0d8-c49d-cddb-e053-3a05fe0aa144
|
7
|
|
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study, file 09cf2c56-243d-4281-9c8d-8e4aad771430
|
6
|
|
The MoxFo initiative-Mechanisms of action: Biomarkers in multiple sclerosis exercise studies, file 479bf5c6-7e2a-4366-a68c-812c0cb30777
|
5
|
|
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection, file b6f6f2e6-5fd8-4ce4-a619-88d576ecd638
|
5
|
|
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy, file ceb8e82e-74eb-4fd2-8492-633f1b63be5f
|
5
|
|
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis, file e291c0d8-e264-cddb-e053-3a05fe0aa144
|
5
|
|
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis, file 17133c49-8401-4039-825a-1d9489ffc13b
|
4
|
|
Fingolimod reduces the clinical expression of active demyelinating lesions in MS, file 2ee5f87b-61f8-49bd-8dd7-773e1ecdcb11
|
4
|
|
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study), file 3537ad05-e5ca-43aa-b084-7609203c785d
|
4
|
|
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study, file 3600f8fb-8057-4f3e-8d6c-90c0bff03362
|
4
|
|
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis, file 3c503d4f-2d68-49b1-b905-3fc1f2417147
|
4
|
|
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study, file 42fe5a16-26df-484a-92ba-61f2095dc186
|
4
|
|
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course, file 4b9bdf08-e469-41c1-9242-74fa86aabf42
|
4
|
|
Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis, file 65f4c264-7c73-4b2f-a649-d5acf520cf43
|
4
|
|
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis, file 6946e071-6e0a-4c2d-bdf0-f4a2389bbc09
|
4
|
|
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression, file 7c74cd0d-1ecb-4137-b496-1d976ab5bb4f
|
4
|
|
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study, file 841cb4ce-b2e6-4647-8b30-32504d5417f8
|
4
|
|
Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis, file 87b4b942-f984-42db-8bba-e73fb1953899
|
4
|
|
Fingolimod reduces the clinical expression of active demyelinating lesions in MS, file 925e637c-0acb-4143-a9e9-613a5b9656d2
|
4
|
|
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis, file 9f4046c3-d54e-4882-b428-62c8f11e394a
|
4
|
|
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis, file b3898c2a-2c8d-4e3b-8a2e-20f049b8998a
|
4
|
|
Lipocalin-2 promotes adipose-macrophage interactions to shape peripheral and central inflammatory responses in experimental autoimmune encephalomyelitis, file deccfd05-8067-4573-a02b-127ecb6efbf1
|
4
|
|
Disability in multiple sclerosis: When synaptic long-term potentiation fails, file e291c0d5-2a0e-cddb-e053-3a05fe0aa144
|
4
|
|
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4, file 3d175b71-1b46-4bb1-b7bf-d1414b6fe044
|
3
|
|
An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study, file 8762d1dd-a02a-4706-9841-26868569096a
|
3
|
|
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.", file f1190809-2c96-4b2c-aff2-5882cfc78884
|
3
|
|
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration, file f8fb9db5-84bd-4f8b-b540-ce485ecaa0df
|
3
|
|
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.", file 18fa3c9b-1f53-44dd-a0a2-ebfc23006c36
|
2
|
|
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care, file 43d80f87-f85b-4417-bc21-b999d68a21d1
|
2
|
|
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study, file 52bb8f12-1219-4722-9717-88347fc80165
|
2
|
|
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis, file 60999056-be78-4cb3-93f9-cb341566c399
|
2
|
|
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study, file 7725a7ea-1390-4fa1-ab8d-dea9187d5bb8
|
2
|
|
null, file 8d15f280-d692-4271-ab6d-438d37a88ef8
|
2
|
|
Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod, file a1cb2146-c01d-48be-bd62-b66fbc320b17
|
2
|
|
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis, file d5fe33d4-67ba-4368-930b-c2cfd05449d8
|
2
|
|
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity, file e291c0d5-23d3-cddb-e053-3a05fe0aa144
|
2
|
|
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis, file e291c0d5-84fe-cddb-e053-3a05fe0aa144
|
2
|
|
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis, file e291c0d6-21ba-cddb-e053-3a05fe0aa144
|
2
|
|
Functional assessment of outer and middle macular layers in multiple sclerosis, file e291c0d8-fd83-cddb-e053-3a05fe0aa144
|
2
|
|
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis, file e291c0d9-b7af-cddb-e053-3a05fe0aa144
|
2
|
|
Optimizing the "Time to pregnancy" in women with multiple sclerosis: the OPTIMUS Delphi survey, file 073edead-a177-433a-88a6-cc81c5297495
|
1
|
|
Laquinimod for treatment of cannabinoid
receptor type 1(cb1) mediated disorders, file e291c0d4-c0e6-cddb-e053-3a05fe0aa144
|
1
|
|
Laquinimod for treatment of gaba mediated
disorders, file e291c0d4-c148-cddb-e053-3a05fe0aa144
|
1
|
|
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis, file e291c0d6-28c0-cddb-e053-3a05fe0aa144
|
1
|
|
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis, file e291c0d6-2ab1-cddb-e053-3a05fe0aa144
|
1
|
|
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53, file e291c0d6-2d83-cddb-e053-3a05fe0aa144
|
1
|
|
D-aspartate: an atypical amino acid with neuromodulatory activity in mammals, file e291c0d7-b2d3-cddb-e053-3a05fe0aa144
|
1
|
|
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility, file e291c0d8-538d-cddb-e053-3a05fe0aa144
|
1
|
|
Beyond rehabilitation in MS: Insights from non-invasive brain stimulation, file e291c0d8-d69c-cddb-e053-3a05fe0aa144
|
1
|
|
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis, file e291c0d9-021e-cddb-e053-3a05fe0aa144
|
1
|
|
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study), file ee4db205-2ef3-41ad-a5b5-9d227d8c95c6
|
1
|
| Totale |
5.093 |